Aktie A1H7XE THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Therapeutic Solutions International, Inc.

Aktien

A1H7XE

US8833781011

TSOI

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:34:48 25.06.2024 		% 5 Tage % 1. Jan.
0,00085 USD -5,56 % Intraday Chart für Therapeutic Solutions International, Inc. +28,57 % -10,00 %
30.05. Therapeutic Solutions International, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
17.04. Therapeutic Solutions International, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Therapeutic Solutions International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Therapeutic Solutions International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Therapeutic Solutions International Receives Patent on Commercially Available QuadraMune Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
Therapeutic Solutions International, Inc. Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease
Therapeutic Solutions International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Therapeutic Solutions International, Inc. Announces Successful First Treatment of Patient with FloraStilbene
Res Nova Bio Appoints George Delgado to Scientific Advisory Board
Therapeutic Solutions International, Inc. Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils
Penny Stock Momentum Watchlist (SWISF, IMTL, NIR, TSOI)
Therapeutic Solutions International Appoints Navneet Boddu to Scientific Advisory Board
Exploring Four Penny Stocks With Recent Headlines (ATVK, ABML, TSOI, IQST)
Therapeutic Solutions International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Therapeutic Solutions International, Inc. Announces FlorStilbene?? Demonstrates Synergy with Conventional Chemotherapy and Immunotherapy in Reducing Triple Negative Breast Cancer
Allogen Biologics Inc. Successfully Manufactures JadiCell
Friday's OTC Noteworthy News Watchlist (EPAZ, TSOI, DPLS, SHMN)
Therapeutic Solutions International Subsidiary Res Nova Bio Inc Discovers New Mechanism of Action for Breast Cancer Immunotherapy Adjuvant FloraStilbene?
Therapeutic Solutions International Files for Orphan Drug Designation Use of JadiCell Adult Stem Cells for Treatment of Frontotemporal Dementia
CapitalGainsReport: Exploring Recent Developments of 4 OTC Stocks (EPAZ, TSOI, GRCU, SIRC)
Therapeutic Solutions International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CapitalGainsReport: Exploring Four Stocks Under a Penny Poised to Pop (HBRM, TSOI, CNNA, AITX)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1H7XE Aktie
  4. Nachrichten Therapeutic Solutions International, Inc.
  5. Andere Sprachen